The lack of information and ignorance mean that those affected by epilepsy suffer certain social stigmas that harm them. Sometimes, people with epilepsy claim that social prejudice affects them more than the disease itself. Below we detail false myths about epilepsy. If together we can bring them down, we will improve the quality of life of the 50 million people affected by epilepsy worldwide according to the World Health Organization (WHO).

Touch the items to reveal explanation  

Epilepsy is a mental illness

It is wrong to assume someone with epilepsy has a psychiatric disorder as epilepsy itself is not a mental illness.

Epilepsy is a rare disease

According to the WHO, 50,000,000 people in the world suffer epilepsy. This means that one in 100 is affected.

Flashing lights cause epilepsy

Light flashes only affect people suffering photosensitive epilepsy, which usually affects children and young people. Lights alone do not cause epilepsy.

An epileptic seizure causes violent convulsions

There are different degrees of seizures. There are, for example, partial ones, which do not cause loss of consciousness and may even go unnoticed.

Epilepsy is contagious through physical contact

There are genetic and physical factors, among others, that can lead to epilepsy, but never physical contact with other people.

You should put something in a person’s mouth to stop them from swallowing their tongue during a seizure

It is physically impossible to swallow your tongue. You can harm yourself or the person’s teeth, jaw and mouth if you try to force something into their mouth.
Open chat
Contact with us now
Chat with Anna
¡Hola! 👋🏻
Soy Anna, ¿en qué puedo ayudarte?

The user who fills in the information requested in this form declares to be entitled to do so and is solely responsible for the accuracy and completeness of the data and information entered, expressly exonerating MJN NEUROSERVEIS of any liability that may arise for this entity on the occasion of the information provided through this form.

Yes, I accept

L’usuari que complimenta la informació requerida al present formulari declara estar legitimat per això i es fa responsable exclusiu de la veracitat i integritat de les dades i informació que introdueix, exonerant expressament a MJN NEUROSERVEIS de qualsevol responsabilitat que es pugi generar per aquesta entitat amb ocasió de la informació facilitat a través del present formulari.

Si, accepto

El usuario que cumplimenta la información requerida en el presente formulario declara estar legitimado para ello y se hace responsable exclusivo de la veracidad e integridad de los datos e información que introduce, exonerando expresamente a MJN NEUROSERVEIS de cualquier responsabilidad que pudiera generarse para esta entidad con ocasión de la información facilitada a través del presente formulario.

Sí, acepto

Save the date

The next Saturday 21st of November at 4 pm, you will be able to know first hand our product: mjn-SERAS.
mjn-SERAS is a healthcare product that sends a warning signal when the risk of epileptic seizures is high, to the affected person and their trusted contacts.

Sign up now!

    mjn-SERAS is a medical device with CE marking according to the European Directive 93/42/EEC and the Royal Decree RD. 1591/2009.
    Contraindications: Do not use the product if you suffer from an infection in the ear canal or if you suffer from a skin lesion in the vicinity of the product's area of influence.
    Considerations: This medical product works with an APP only on Android phones. The results tested are 96% sensitivity and 94% specificity.

    Save the date

    El próximo sábado 21 de noviembre a las 4 de la tarde, podrás conocer de primera mano nuestro producto: mjn-SERAS.
    mjn-SERAS es un producto sanitario que lanza una señal de aviso cuando el riesgo de crisis de epilepsia es elevado, a la persona afectada y a sus contactos de confianza.


      mjn-SERAS es un producto sanitario con marcado CE conforme a la Directiva Europea 93/42/EEC y el Real Decreto RD. 1591/2009.
      Contraindicaciones: No usar el producto en caso de padecer una infección en el canal auditivo o en caso de padecer una lesión cutánea en las proximidades del área de influencia del producto.
      Consideraciones: Este producto sanitario funciona con una APP solo en teléfonos Android. Los resultados testeados son 96% de sensibilidad y 94% de especificidad.